Trial intelligence / Profile preview

Premedication for less invasive surfactant administration

2018-002383-38Phase 4Active

Sponsor
University of Oulu
Start
Oct 2018
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in respiratory distress syndrome (RDS) comparing Ketamine premedication with Fentanyl premedication (2 arms). Primary endpoint: Adverse events during LISA procedure. Started Oct 2018; status: active.

02

Drugs

ketaminefentanyl
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on 2018-002383-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002383-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call